Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
TriSalus Life Sciences Fourth Quarter 2025 Earnings Call - $46M Raise, Doubling Sales Force and Reaffirming $60-62M 2026 Revenue with Back-Loaded Growth
TriSalus closed 2025 with strong top-line momentum, raising $46 million in a well-subscribed public offering and reporting Q4 revenue of $13.2 million and full-year revenue of $45.2 million. Managemen...
- Q4 2025 revenue was $13.2 million, up 60% year over year; full-year 2025 revenue was $45.2 million, up 53% year over year.
- TriSalus completed a public offering in February that raised $46 million in gross proceeds, the deal was more than two times oversubscribed and brought in fundamental healthcare investors.
- Management reaffirmed 2026 revenue guidance at $60 million to $62 million, and expects roughly 40% of 2026 revenue in H1 and 60% in H2 due to onboarding and territory realignment.
- +11 more takeaways
AerSale Q4 2025 Earnings Call - Shift to recurring revenue and disciplined feedstock buying drives margin expansion
AerSale closed 2025 with improving profitability despite a stumble in headline revenue. Q4 adjusted EBITDA rose to $15.2 million, up 17.1% year over year, while full year adjusted EBITDA surged to $46...
- Q4 adjusted EBITDA was $15.2 million, up 17.1% versus Q4 2024.
- Full year 2025 adjusted EBITDA rose to $46.1 million, up 38.2% year over year; full year revenue was $335.3 million, down 2.8%.
- Q4 revenue was $90.9 million, down 4% YoY; management says excluding flight equipment sales revenue increased about 9.8%.
- +12 more takeaways
Inuvo, Inc. Q4 2025 Earnings Call - IntentKey pivot targets higher-margin data and enterprise deals as Platforms revenue rebalances
Inuvo reported a sharp fourth quarter platform revenue pullback while pushing a strategic pivot toward IntentKey, its AI-driven intent product, as the path to higher-margin, recurring data and enterpr...
- Q4 2025 revenue was $14.3 million, a 46% decline versus Q4 2024, driven by an intentional pullback in platform products.
- Q4 gross profit fell to $9.5 million, down 56% year over year, and Q4 operating loss was $1.2 million.
- Q4 net loss was $594,000, or $0.04 per share, while adjusted EBITDA for the quarter was $360,000.
- +15 more takeaways
BioLargo 2025 Annual Earnings Call - Commercial inflection as Clyra launches and EPA monitors AEC PFAS demo
BioLargo frames 2025 as a pivot year, moving from development to commercialization across four proprietary platforms. Management points to concrete validation events: Clyra Medical shipped its first p...
- Company filed its 10-K and positions 2025 as a decisive transition from R&D to commercialization across four platforms: Clyra Medical, Cellinity Battery, AEC Water Treatment, and ONM Environmental.
- BioLargo retains significant equity in its subsidiaries, reported ownership stakes ranging from 49% to 100%, and receives a 6% royalty on sales as a recurring corporate revenue stream.
- Clyra Medical: ViaCLYR is FDA 510(k) cleared, presented clinical data at the 48th Annual Boswick Symposium, and the company has an exclusive distribution agreement with a large distributor, with its first commercial stocking order shipped and paid.
- +12 more takeaways
Intrepid Potash, Inc. Fourth Quarter 2025 Earnings Call - Trio Surge and Maiden Lithium Resource Put Growth Back on the Table
Intrepid closed 2025 with a clear breakout year, driven by record Trio volumes, stronger pricing, and tighter unit costs. Adjusted EBITDA of $63 million, roughly an 80 percent improvement year over ye...
- Adjusted EBITDA for 2025 was $63 million, an almost 80% improvement versus 2024; Q4 adjusted EBITDA was $18.1 million and adjusted net income was $6.5 million.
- Total fertilizer sales volumes in 2025 reached ~592,000 tons, about 20% higher than 2024; Trio sales hit a company record at 303,000 tons.
- Trio delivered the strongest segment performance in company history outside of 2022 pricing, with Q4 realized Trio price of $379 per ton, and a 20% price gain versus Q1 2025.
- +12 more takeaways
Ring Energy Q4 2025 Earnings Call - Discipline Pays: Free Cash Flow, Debt Paydown and Testing Horizontal Upside
Ring closed 2025 having quietly proved its playbook: generate cash, cut costs, pay down debt, and test new horizontal inventory without blowing up the balance sheet. Despite a post-Liberation Day pric...
- Ring delivered its 25th consecutive quarter of adjusted free cash flow, generating $5.7 million in Q4 and $50.1 million for full-year 2025 despite an 18% drop in realized commodity pricing year over year.
- Q4 production sold 20,508 Boe/d, essentially flat sequentially, and 2025 full-year average sales set a company record at 20,253 Boe/d, helped by nine months of production from the March Lime Rock acquisition.
- Realized price fell to $35.45 per Boe in Q4, down 14% from Q3, driven by an 11% sequential decline in realized oil pricing and wider differentials versus NYMEX WTI.
- +12 more takeaways
Acorn Energy Q4 & Full Year 2025 Earnings Call - Monitoring Revenue Surge and AIO Partnership Reframe the Growth Story
Acorn closed 2025 with record revenue, stronger cash flow, and its third consecutive profitable year, driven by a 22% jump in high-margin monitoring revenue and product cost efficiencies that lifted g...
- Total 2025 revenue rose 4.5% to $11.478 million, with monitoring revenue up 22% driven by expansion of monitored endpoints.
- Monitoring revenue is the core value driver, described by management as achieving a 95% growth margin in 2025 and contributing to higher overall gross margins.
- Gross margin improved 400 basis points to 76.8%, attributed to the monitoring mix and lower hardware costs from next-generation products.
- +12 more takeaways
Grupo Financiero Galicia Q4 2025 Earnings Call - Asset-quality spike sinks results; 2026 recovery hinges on credit cycle and inflation
Grupo Financiero Galicia closed 2025 with a sharply weaker bottom line after a surge in retail delinquencies and heavy provisioning. Net income for the year was ARS 196 billion, down 91% year over yea...
- 2025 full-year net income ARS 196 billion, down 91% year over year; return on average assets 0.4% and ROE 2.5% (excluding integration expenses net result would be ARS 333 billion and ROE ~4.2%).
- Q4 2025 produced a net loss of ARS 84 billion; Banco Galicia posted an ARS 104 billion loss in the quarter and Naranja X an ARS 49 billion loss, partly offset by Galicia Asset Management and Galicia Seguros profits.
- Retail asset quality deterioration was the main culprit: retail NPLs jumped to 14.3% from 3.2% at year-end 2024; overall NPLs rose to 6.9% from 5.8% quarter over quarter.
- +12 more takeaways
Janus International Group Q4 and FY2025 Earnings Call - Guidance Relies on Kiwi II to Offset Weak North America New Construction
Janus closed 2025 on steady cash and a deliberate playbook. Full-year revenue was $884.2 million with $168.2 million of adjusted EBITDA, and management set 2026 guidance of $940 million to $980 millio...
- Full-year 2025 revenue was $884.2 million, with adjusted EBITDA of $168.2 million.
- Q4 2025 revenue totaled $226.3 million, down 1.9% year-over-year; Q4 adjusted EBITDA was $37.2 million, up 7.5%, and margin expanded to 16.4% (up ~140 bps).
- 2026 guidance: revenue $940 million to $980 million (about +8.6% at midpoint vs 2025) and adjusted EBITDA $165 million to $185 million (about +4% at midpoint).
- +12 more takeaways
Ellington Credit Company Q4 2025 Earnings Call - Active shift into CLO mezzanine debt limited NAV loss to ~9%
Ellington Credit reported a difficult Q4 driven by a broad CLO equity selloff, recording a GAAP net loss of $0.56 per share and a quarter NAV total return of negative 9.1%, leaving NAV at $5.19 per sh...
- Q4 GAAP net loss was $0.56 per share, with NAV at $5.19 per share as of December 31, 2025 and a NAV total return for the quarter of negative 9.1%.
- Ellington says its active trading and tilt toward CLO mezzanine debt limited fund losses to roughly 9% of NAV, outperforming the broader CLO equity peer group.
- Since converting to a CLO closed-end fund on April 1, 2025, the CLO portfolio expanded by nearly 50% to about $370 million by year-end.
- +12 more takeaways